These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17707829)

  • 1. Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells.
    Chiorazzi N
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):399-413. PubMed ID: 17707829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
    De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G
    Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells.
    de Vries JF; Falkenburg JH; Willemze R; Barge RM
    Haematologica; 2006 Jul; 91(7):912-9. PubMed ID: 16818278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow.
    van Gent R; Kater AP; Otto SA; Jaspers A; Borghans JA; Vrisekoop N; Ackermans MA; Ruiter AF; Wittebol S; Eldering E; van Oers MH; Tesselaar K; Kersten MJ; Miedema F
    Cancer Res; 2008 Dec; 68(24):10137-44. PubMed ID: 19074880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.
    De Fanis U; Dalla Mora L; Romano C; Sellitto A; Tirelli A; Lucivero G
    Haematologica; 2002 Mar; 87(3):325-7. PubMed ID: 11869948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
    Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation ability of the CLL lymphocyte: an immature lymphocyte or an abnormal leukemic cell?
    Dighiero G; Bodega E; Binet JL
    Blood Cells; 1981; 7(2):331-9. PubMed ID: 6975143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional properties of B-lymphocytes of patients with a B-cell variant of chronic lymphocytic leukemia and chronic glomerulonephritis].
    Ostanin AA; Chernykh ER; Shubinskiĭ GZ; Nekipelova VI; Tov NL; Lozovoĭ VP
    Vestn Akad Med Nauk SSSR; 1991; (12):19-23. PubMed ID: 1801468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in B-CLL: the relationship between higher ex vivo spontaneous apoptosis before treatment in III-IV Rai stage patients and poor outcome.
    Sieklucka M; Pozarowski P; Bojarska-Junak A; Hus I; Dmoszynska A; Rolinski J
    Oncol Rep; 2008 Jun; 19(6):1611-20. PubMed ID: 18497973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.
    Messmer BT; Messmer D; Allen SL; Kolitz JE; Kudalkar P; Cesar D; Murphy EJ; Koduru P; Ferrarini M; Zupo S; Cutrona G; Damle RN; Wasil T; Rai KR; Hellerstein MK; Chiorazzi N
    J Clin Invest; 2005 Mar; 115(3):755-64. PubMed ID: 15711642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress accelerates spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes.
    Djurdjevic P; Zelen I; Ristic P; Jovanovic I; Jakovljevic V; Baskic D; Popovic S; Arsenijevic N
    J BUON; 2009; 14(2):281-7. PubMed ID: 19650179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
    Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
    Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes.
    Martinez-Taboada V; Brack A; Hunder GG; Goronzy JJ; Weyand CM
    J Rheumatol; 1996 Jun; 23(6):1011-4. PubMed ID: 8782132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prohibitin expression is increased in phorbol ester-treated chronic leukemic B-lymphocytes.
    Woodlock TJ; Bethlendy G; Segel GB
    Blood Cells Mol Dis; 2001; 27(1):27-34. PubMed ID: 11162143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
    Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
    Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.